ATLANTA and BOSTON – July 28, 2022 – Global law firm Greenberg Traurig, LLP Shareholders Lori G. Cohen and David J. Dykeman are shortlisted to receive LMG Life Sciences Attorney of the Year awards. Winners will be announced at an event to be held in New York Sept. 8.
Cohen, who is vice chair of Greenberg Traurig and co-chair of the firm’s Global Litigation Practice and Trial Practice, is shortlisted for Product Liability Attorney of the Year. Dykeman, who is co-managing shareholder of Greenberg Traurig's Boston office and co-chairs the firm's Global Life Sciences & Medical Technology Group, is shortlisted for Patent Strategy Attorney of the Year – Massachusetts.
LMG Life Sciences is considered the definitive guide to leading U.S., Canada, Europe, Middle East, and Africa law firms and lawyers specializing in the life sciences industry. The guide’s LMG Life Sciences Awards recognize key law firms, lawyers, and the innovative work accomplished throughout the life sciences industry. They are based on marketplace and client feedback, as well as information provided by firms, which can only be ranked if the market deems them worthy of consideration.
Cohen has been honored by LMG Life Sciences with several Attorney of the Year awards, inducted into its Life Sciences Hall of Fame, and been listed as an LMG Life Sciences Star since 2012. Nationally recognized for her extraordinary trial record of 58 defense verdicts, she leads a global practice that focuses on complex litigation of all types, including products liability and pharmaceutical, medical device, and health care litigation. Cohen has served as national, regional, and trial counsel for numerous medical device and pharmaceutical manufacturers, handling all types of litigation, including class actions, multidistrict litigation, and trials nationally. Cohen and her team routinely take complex cases to trial and win, including some of the most complex mass torts in history. Well known for her ability to win high-stakes trials, Cohen is often called upon to “parachute in” at the last minute before trial, especially in challenging cases and jurisdictions.
Dykeman, who has been listed as a LMG Life Sciences Star since 2014, is a registered patent attorney with 25 years of experience in patent and intellectual property law. His practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman provides strategic patent portfolio development and intellectual property advice for clients, including major research institutions, multinational corporations, and startup companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on intellectual property law, Dykeman is the founding co-chair of the American Bar Association’s Medical Devices Committee.
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig’s Products Liability & Mass Torts Litigation Practice: The Products Liability & Mass Torts Litigation Practice is an integral part of Greenberg Traurig’s 600-plus member global Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. The team was The American Lawyer’s 2018 “Products Liability Litigation Department of the Year.” Additional recent recognitions include national rankings for “Products Liability & Mass Torts” from Chambers USA; national rankings for “Product Liability & Mass Torts Defense” from The Legal 500 United States; and a first-tier national ranking for “Mass Tort Litigation / Class Actions – Defendants” from U.S. News – Best Lawyers® “Best Law Firms.” In addition, Greenberg Traurig is recognized as a “Product Liability Litigation Leader” in the 2021 BTI Litigation Outlook, published by BTI Consulting Group.
About Greenberg Traurig: Greenberg Traurig, LLP has more than 2400 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm, often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono, reported gross revenue of over $2 Billion for FY 2021. The firm is consistently among the top firms on the Am Law 100, Am Law Global 100, NLJ 250, and Law360 (US) 400. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 4.0 Certified Plus by The Diversity Lab and net carbon neutral with respect to its office energy usage. Web: www.gtlaw.com.